These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 635859)
21. [Use of hydrocortisone sodium hemisuccinate in the prevention of allergy to radiographic contrast media used in urography and cholangiography]. Martignoni R; Bormida L Clin Ter; 1970 Apr; 53(1):33-62. PubMed ID: 5507424 [No Abstract] [Full Text] [Related]
22. Anaphylactic death from methylglucamine and sodium diatrizoate (Renovist). Shoultz CA; Dines DE; Peters GA; Witten DM Ann Allergy; 1968 Jan; 26(1):40-3. PubMed ID: 4951626 [No Abstract] [Full Text] [Related]
23. [Biligram--a new hepatotropic contrast medium for infusion cholecysto-cholangiography]. Lazecki L Pol Przegl Radiol Med Nukl; 1972; 36(6):775-8. PubMed ID: 4660877 [No Abstract] [Full Text] [Related]
24. [Prevention of side effects in intravenous cholangiocystography. 1]. Preuss HJ Dtsch Gesundheitsw; 1971 Oct; 26(42):1985-90. PubMed ID: 5144066 [No Abstract] [Full Text] [Related]
25. [Complications after the use of methylglucamine in spinal perimyelography]. Pinta Z; Skrivánek O Cesk Neurol Neurochir; 1980 Nov; 43(6):421-3. PubMed ID: 7438250 [No Abstract] [Full Text] [Related]
26. [The results and tolerability of infusion cholegraphy using ioglycamide-85 (12.75 g meglumine salt in 75 ml) in comparison with the use of a hypotonic adipiodone solution (10 g meglumine salt in 100 ml)]. Ronneburg HP Radiol Diagn (Berl); 1990; 31(3):253-60. PubMed ID: 2367631 [TBL] [Abstract][Full Text] [Related]
27. [Prevention of complications of perfusion cholangiography. Comparison between corticoids and tranexamic acid]. Wangermez J J Radiol Electrol Med Nucl; 1975; 56 suppl 1():142. PubMed ID: 1232124 [No Abstract] [Full Text] [Related]
30. [Biligram, a new contrast medium for the biliary tract (Biligram injection)]. Aoyama B; Kato T; Nishio T; Takenaka S; Nomoto H Rinsho Hoshasen; 1971 Dec; 16(12):1001-8. PubMed ID: 5211729 [No Abstract] [Full Text] [Related]
31. Fatal adverse event secondary to high osmolality contrast agent. Guharoy R; Medicis J; Lehmann D Vet Hum Toxicol; 1998 Oct; 40(5):285-7. PubMed ID: 9778765 [TBL] [Abstract][Full Text] [Related]
32. [Complications of intravenous cholangiography. Results of an inquiry launched by the French Radiological Society]. Nahum H; Desbleds MT; Marsault C J Radiol Electrol Med Nucl; 1975; 56(8-9):595-7. PubMed ID: 1185702 [No Abstract] [Full Text] [Related]
33. [Choledochopancreatic reflux in cholangiography and its connection with postoperative pancreatitis]. Zakharov VP Klin Khir (1962); 1971 Oct; 10():25-7. PubMed ID: 5140248 [No Abstract] [Full Text] [Related]
34. Meglumine hepatotoxicity. Imoto S Ann Intern Med; 1978 Jan; 88(1):129. PubMed ID: 619742 [No Abstract] [Full Text] [Related]
35. [Biligram and Biligram for infusion are the new biliary contrast media from Schering]. Rontgenpraxis; 1971 Sep; 24(9):217-8. PubMed ID: 4329797 [No Abstract] [Full Text] [Related]
36. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media]. Limido G Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500 [No Abstract] [Full Text] [Related]
37. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance]. Campos A; Aznar L; Alamar R; Castelló JV Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023 [No Abstract] [Full Text] [Related]
38. [Complication after intravenous administration of Bilignost in cholegraphy]. Shubinskiĭ NA Vrach Delo; 1968 Nov; 11():120-1. PubMed ID: 5744880 [No Abstract] [Full Text] [Related]